Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ionis Pharmaceuticals

41.76
-0.4100-0.97%
Post-market: 41.760.00000.00%16:10 EDT
Volume:1.27M
Turnover:52.83M
Market Cap:6.65B
PE:-13.93
High:42.57
Open:42.15
Low:41.25
Close:42.17
Loading ...

Stock Track | Ionis Pharmaceuticals Soars 6.88% Pre-Market on Strong Q1 Results and Raised 2025 Guidance

Stock Track
·
30 Apr

Ionis Pharmaceuticals (IONS) Reports Q1 Earnings: What Key Metrics Have to Say

Zacks
·
30 Apr

Ionis Pharmaceuticals Q1 Net Loss Narrows as Revenue Increases; 2025 Revenue Guidance Raised

MT Newswires Live
·
30 Apr

Ionis Pharmaceuticals (IONS) Reports Q1 Loss, Tops Revenue Estimates

Zacks
·
30 Apr

Ionis Pharmaceuticals: Q1 Earnings Snapshot

Associated Press Finance
·
30 Apr

Earnings Flash (IONS) Ionis Pharmaceuticals Posts Q1 EPS Loss $0.93, vs. FactSet Est of $1.10 Loss

MT Newswires Live
·
30 Apr

Ionis Pharmaceuticals Q1 Adj. EPS $(0.93) Beats $(1.12) Estimate, Sales $132.00M Beat $125.32M Estimate

Benzinga
·
30 Apr

BRIEF-Ionis Pharmaceuticals Q1 Revenue USD 132 Million Vs. IBES Estimate USD 125.3 Million

Reuters
·
30 Apr

Ionis Pharmaceuticals Inc: Increasing 2025 Financial Guidance by More Than 20%

THOMSON REUTERS
·
30 Apr

Ionis Pharmaceuticals Inc Outlook 2025 REV $725 Mln -$750 Mln

THOMSON REUTERS
·
30 Apr

Ionis Pharmaceuticals: on Track for Second Independent Launch With Donidalorsen Pdufa August 21, 2025

THOMSON REUTERS
·
30 Apr

Ionis reports first quarter 2025 financial results

Business Wire
·
30 Apr

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
30 Apr

New Harris Poll findings reveal HAE patients are unsatisfied with current prophylactic treatment options, with over 90% interested in trying new therapies

Business Wire
·
29 Apr

Press Release: Ionis to hold first quarter 2025 financial results webcast

Dow Jones
·
16 Apr

Ionis Pharmaceuticals Price Target Maintained With a $60.00/Share by Needham

Dow Jones
·
15 Apr

Ionis Pharmaceuticals price target lowered to $52 from $55 at Morgan Stanley

TIPRANKS
·
11 Apr

Morgan Stanley Keeps Their Hold Rating on Ionis Pharmaceuticals (IONS)

TIPRANKS
·
11 Apr

Ionis Pharmaceuticals (IONS) Surges 8.9%: Is This an Indication of Further Gains?

Zacks
·
10 Apr

Ionis Pharmaceuticals Price Target Maintained With a $60.00/Share by Needham

Dow Jones
·
08 Apr